157 filings
Page 5 of 8
6-K
1jbv4999 uz
5 May 22
Current report (foreign)
4:59pm
6-K
ynd9mgkv4s
26 Apr 22
Valneva Provides Regulatory Update on its inactivated COVID-19 Vaccine Candidate
11:00am
6-K
7jiz f4d5
19 Apr 22
Valneva Receives Conditional Marketing Authorization from UK MHRA for its Inactivated COVID-19 Vaccine
6:00am
6-K
ue2k7f4xj26
25 Mar 22
Valneva Reports Full Year 2021 Results and Provides Corporate Updates
7:24am
20-F
vod9d ilhmqz9iw
24 Mar 22
Annual report (foreign)
12:32pm
6-K
24jlzxnkfj
22 Mar 22
Valneva Announces Renewal of the Term of Office of its Management Board Members
1:00pm
6-K
ye7khdy98l
14 Mar 22
Valneva Provides Regulatory Update on its COVID-19 Vaccine Candidate
9:00am
6-K
xl0fr hsvs
8 Mar 22
Valneva Successfully Completes Pivotal Phase 3 Trial of Single-Shot Chikungunya Vaccine Candidate
5:00pm
6-K
sz0yhxlhvx8a8swejb8
1 Mar 22
Valneva Receives Initial CHMP Assessment of its Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001
9:00am
6-K
6r1in 9wv5
23 Feb 22
Valneva Awarded Up to £20 Million by Scottish Enterprise to Advance Vaccine Development
4:30pm
6-K
hfijiecydruyk 4ewhil
4 Feb 22
Valneva Reports Full Year 2021 Revenue and Cash; Provides First 2022 Guidance
9:00am
6-K
zc7xj
1 Feb 22
Valneva Announces Initiation of Adolescent Phase 3 Trial for its Single-Shot Chikungunya Vaccine Candidate
4:30pm
6-K
96063
26 Jan 22
Valneva Advances Booster Phase of Cov-Compare Trial of Its Inactivated COVID-19 Vaccine Candidate
4:45pm
6-K
72x9u awo
19 Jan 22
Current report (foreign)
2:00pm
6-K
rlbxb99iy5ouw17em
10 Jan 22
Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vaccine Candidate VLA2001
9:00am
6-K
frm35wg4
23 Dec 21
Valneva Announces Positive Lot-to-Lot Consistency Trial Results for its Single-Shot Chikungunya Vaccine Candidate
1:00pm
6-K
849p2o
16 Dec 21
Valneva Announces Positive Homologous Booster Data for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001
5:00pm
6-K
f8cmh 0an
9 Dec 21
Valneva Signs Advance Purchase Agreement with Bahrain for Inactivated COVID-19 Vaccine VLA2001
12:00pm
6-K
ienxts ou
3 Dec 21
Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001
5:00pm
6-K
ww51 ry6b82a
26 Nov 21
Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA2001
12:00pm